Ann: Investor Briefing, page-58

Im pretty sure that in the last update they advised that they were sending in a written submission (Revised Growth Plan) on 28th October which was delivered via webinar / in person the week before

There was no mention on when CBI would respond back but reading between the lines it isn't clear on whether:

a) the argument is between Growth % on new programs being rolled out between now and when CBI issue is resolved (likely Q1)
b) the argument is around the Growth % for PCSIL business moving forward in perpetuity. e.g. a cap on the number of programs the company ants to rollout each year and the supposed DD they do with each one

I suspect its mainly (a) with a tiny bit of (b) which is being resolved by implementing new AML Technology and doubling the regulatory headcount

I don't expect any announcement until the AGM unless the CBI comes back with a % Growth figure that Tom, Rob and the Board are ok with